These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8542617)

  • 1. Treatment of vascular disease with local drug delivery systems.
    Makkar RR; Litvack F; Eigler N; Forrester JS
    Cardiologia; 1995 Sep; 40(9):651-7. PubMed ID: 8542617
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of delivery and local drug delivery technologies.
    Bailey SR
    Semin Interv Cardiol; 1996 Mar; 1(1):17-23. PubMed ID: 9552481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy.
    Xu Z; Yang G; Reinstein LE; Cole PE
    Cardiovasc Radiat Med; 2000; 2(1):26-31. PubMed ID: 11229058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular brachytherapy: applications in the era of drug-eluting stents.
    Waksman R
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S23-30. PubMed ID: 12478232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double balloon catheter.
    Enger C; Wolinsky H
    Semin Interv Cardiol; 1996 Mar; 1(1):27-8. PubMed ID: 9552482
    [No Abstract]   [Full Text] [Related]  

  • 6. Nipple balloon catheter.
    Barath P; Popov A; Michiels R
    Semin Interv Cardiol; 1996 Mar; 1(1):43. PubMed ID: 9552489
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual balloon catheter.
    Gunn J; Cumberland DC
    Semin Interv Cardiol; 1996 Mar; 1(1):31-3. PubMed ID: 9552484
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrogel-coated balloon catheter.
    McKay RG
    Semin Interv Cardiol; 1996 Mar; 1(1):45-6. PubMed ID: 9552491
    [No Abstract]   [Full Text] [Related]  

  • 9. Coil balloon catheter.
    Camenzind E; Harrison K
    Semin Interv Cardiol; 1996 Mar; 1(1):39-40. PubMed ID: 9552487
    [No Abstract]   [Full Text] [Related]  

  • 10. Porous balloon catheters.
    Enger C; Wolinsky H
    Semin Interv Cardiol; 1996 Mar; 1(1):28-9. PubMed ID: 9556372
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local drug administration systems, preclinical and clinical use: perspectives and limitations].
    Gonschior P; Wilensky R; March K; Höfling B
    Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
    Lepor NE; Madyoon H; Kereiakes D
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effectiveness and safety of drug-eluting stents versus vascular brachytherapy for saphenous vein graft in-stent restenosis.
    Mishra S; Wolfram RM; Torguson R; Chu WW; Xue Z; Gevorkian N; Donekal S; Chan R; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 May; 97(9):1303-7. PubMed ID: 16635600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different application parameters on penetration characteristics and arterial vessel wall integrity after local nanoparticle delivery using a porous balloon catheter.
    Westedt U; Barbu-Tudoran L; Schaper AK; Kalinowski M; Alfke H; Kissel T
    Eur J Pharm Biopharm; 2004 Jul; 58(1):161-8. PubMed ID: 15207550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local vascular toxicokinetics of stent-based drug delivery.
    Tesfamariam B
    Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
    Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
    Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.
    Noordeloos AM; Soullié T; Duckers HJ; Serruys PW
    Endothelium; 2006; 13(6):431-9. PubMed ID: 17169775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for local drug delivery.
    Eccleston DS; Horrigan MC; Ellis SG
    Semin Interv Cardiol; 1996 Mar; 1(1):8-16. PubMed ID: 9552480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to reduce restenosis.
    Beyar R
    Ann N Y Acad Sci; 2004 May; 1015():367-78. PubMed ID: 15201175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.